All posts by: Michael Zand

About Michael Zand

Who owns CRISPR? – Lab News

Continue reading

2017-01-17 NEWS

Lab News

Who owns CRISPR?
Lab News
As CRISPR establishes a firm foothold as the gene editing technique of choice, the patent lawyers are braced for what may shape up to be science’s bloodiest commercial battle. Dermot Martin gets into the mired battle ground to give us an update

Continue reading

2017-01-17 NEWS

Philly.com

The promise of gene therapy for Eli and Ella, but not Calliope Joy
Philly.com
Alessandra Biffi, the physician/researcher who led the trial at Milan’s San Raffaele Hospital, now directs the gene therapy program at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center. Further, the experimental treatment has been

Continue reading

2017-01-17 NEWS

Philly.com

The promise of gene therapy for Eli and Ella, but not Calliope Joy
Philly.com
Alessandra Biffi, the physician/researcher who led the trial at Milan’s San Raffaele Hospital, now directs the gene therapy program at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center. Further, the experimental treatment has been

and more »

Continue reading

2017-01-17 NEWS

Hedelt: After downer of a holiday movie season, columnist craves laughs
Fredericksburg.com
In “Passengers,” characters who wake up on a space ship heading to populate a new planet are mistakenly brought out of suspended animation so early that they are dead when the rest of the crew is revived as the planet draws near. Then there’s “Assassin

Continue reading

2017-01-17 NEWS

How to rebuild heart’s layers with stem cells
Futurity: Research News
“In 2012, we discovered that if we treated human stem cells with chemicals that sequentially activate and inhibit Wnt signaling pathway, they become myocardium muscle cells,” says Xiaojun Lance Lian, assistant professor of biomedical engineering and …